Robert James Siegel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert James Siegel has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
Huai Luo
Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
21 shared publicationsShaul Atar
Cedars-Sinai Medical Center, Los Angeles, California, USA
8 shared publicationsTakashi Miyamoto
Cedars-Sinai Medical Center, Los Angeles, California, USA
7 shared publicationsKirsten Tolstrup
Cardiac Noninvasive Laboratory , Cedars-Sinai Medical Center , 8700 Beverly Blvd, Room 5623, Los Angeles 90048, CA , USA
6 shared publicationsYochai Birnbaum
Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
6 shared publicationsAsim M. Rafique
5 shared publications
Latest Publications
- 14 January 2026
- Published by Springer Nature
- p. 573-592
Intraprocedural Transesophageal Echocardiography
- 14 January 2026
- Published by Springer Nature
- p. 573-592
Intraprocedural Transesophageal Echocardiography
- 25 October 2018
- Published by Springer Nature
- p. 413-422
Intraprocedural Transesophageal Echocardiography
- 25 October 2018
- Published by Springer Nature
- p. 413-422
Intraprocedural Transesophageal Echocardiography
- 28 January 2017
- Published by Wiley in Echocardiography
- Vol. 34 (3) , 334-339
Mitral annular motion in patients after transcatheter MitraClip and mitral valve surgery
Background: Longitudinal motion of the mitral annulus is an index that reflects left ventricular (LV) function. The aim of this study was to evaluate and compare the effects of transcatheter mitral valve (MV) repair and open heart surgery for mitral regurgitation (MR) on mitral annular motion (MAM).Methods: We retrospectively analyzed in total 115 patients who underwent isolated transcatheter MV repair using MitraClip (n=50) or surgical MV interventions (n=65, 50 repairs and 15 replacements) for MR. MAM was assessed by two‐dimensional B‐mode echocardiography in the four‐ and two‐chamber views. MAM was measured before and within 1 month after the mitral procedure.Results: Compared with patients undergoing MV surgery, patients undergoing the MitraClip procedure were older and had more comorbidities. MR grade improved significantly in both groups after MV intervention. MAM decreased significantly in the surgery group (12.0±3.1 to 8.1±2.2 mm, P<.01), whereas MAM did not change in the MitraClip group (8.8±2.6 to 8.6±2.5 mm, P=.59). In multivariate analysis, mitral surgery was associated with a decrease in MAM when compared to the MitraClip procedure. Furthermore, LV ejection fraction (EF) decreased to a greater degree in patients undergoing surgery than those undergoing MitraClip placement (MV surgery; −10.1±7.6% vs MitraClip; −3.0±10.5%, P<.01).Conclusions: MitraClip therapy does not adversely influence MAM and is associated with less postprocedural EF reduction compared to surgical intervention. Our results suggest that patients with reduced LV systolic function may benefit from the MitraClip procedure compared to mitral surgery.
- 28 January 2017
- Published by Wiley in Echocardiography
- Vol. 34 (3) , 334-339
Mitral annular motion in patients after transcatheter MitraClip and mitral valve surgery
Background: Longitudinal motion of the mitral annulus is an index that reflects left ventricular (LV) function. The aim of this study was to evaluate and compare the effects of transcatheter mitral valve (MV) repair and open heart surgery for mitral regurgitation (MR) on mitral annular motion (MAM).Methods: We retrospectively analyzed in total 115 patients who underwent isolated transcatheter MV repair using MitraClip (n=50) or surgical MV interventions (n=65, 50 repairs and 15 replacements) for MR. MAM was assessed by two‐dimensional B‐mode echocardiography in the four‐ and two‐chamber views. MAM was measured before and within 1 month after the mitral procedure.Results: Compared with patients undergoing MV surgery, patients undergoing the MitraClip procedure were older and had more comorbidities. MR grade improved significantly in both groups after MV intervention. MAM decreased significantly in the surgery group (12.0±3.1 to 8.1±2.2 mm, P<.01), whereas MAM did not change in the MitraClip group (8.8±2.6 to 8.6±2.5 mm, P=.59). In multivariate analysis, mitral surgery was associated with a decrease in MAM when compared to the MitraClip procedure. Furthermore, LV ejection fraction (EF) decreased to a greater degree in patients undergoing surgery than those undergoing MitraClip placement (MV surgery; −10.1±7.6% vs MitraClip; −3.0±10.5%, P<.01).Conclusions: MitraClip therapy does not adversely influence MAM and is associated with less postprocedural EF reduction compared to surgical intervention. Our results suggest that patients with reduced LV systolic function may benefit from the MitraClip procedure compared to mitral surgery.
- Open Access
- 1 July 2016
- Published by BMJ in Open Heart
- Vol. 3 (2) , e000378
Echo-Doppler determinants of outcomes in patients with unoperated significant mitral regurgitation in current era
Objective: One-half of patients with severe symptomatic mitral regurgitation (MR) do not undergo surgery due to comorbidities. We evaluated prognosticators of outcomes in patients with unoperated significant MR. Methods: In this observational study, we retrospectively evaluated medical records of 75 consecutive patients with unoperated significant MR. Results: All-cause mortality was 39% at 5 years. Non-survivors (n=29) versus survivors (n=46) were: older (77±9.8 vs 68±14, p=0.006), had higher New York Heart Association (NYHA) class (2.7±0.8 vs 2.3±0.8, p=0.037), higher brain natriuretic peptide (1157±717 vs 427±502 pg/mL, p=0.024, n=18), more coronary artery disease (61% vs 35%, p=0.031), more frequent left ventricular ejection fraction ′ (12.7±4.6 vs 9.8±4, p=0.008), higher pulmonary artery systolic pressure (PASP; 52.6±18.7 vs 36.7±14, p ′ (p=0.011) using multivariate regression analysis. Conclusions: Patients with unoperated significant MR have high mortality. Elevated PASP and mitral E/E′ were the most significant predictors of 5-year survival in patients with unoperated significant MR. Current American College of Cardiology (ACC)/American Heart Association (AHA) guidelines provide a limited incorporation of echo-Doppler parameters in the preoperative risk stratification of patients with severe MR.
- 1 July 2016
- Published by BMJ in Open Heart
- Vol. 3 (2) , e000378
Open AccessEcho-Doppler determinants of outcomes in patients with unoperated significant mitral regurgitation in current era
Objective: One-half of patients with severe symptomatic mitral regurgitation (MR) do not undergo surgery due to comorbidities. We evaluated prognosticators of outcomes in patients with unoperated significant MR. Methods: In this observational study, we retrospectively evaluated medical records of 75 consecutive patients with unoperated significant MR. Results: All-cause mortality was 39% at 5 years. Non-survivors (n=29) versus survivors (n=46) were: older (77±9.8 vs 68±14, p=0.006), had higher New York Heart Association (NYHA) class (2.7±0.8 vs 2.3±0.8, p=0.037), higher brain natriuretic peptide (1157±717 vs 427±502 pg/mL, p=0.024, n=18), more coronary artery disease (61% vs 35%, p=0.031), more frequent left ventricular ejection fraction ′ (12.7±4.6 vs 9.8±4, p=0.008), higher pulmonary artery systolic pressure (PASP; 52.6±18.7 vs 36.7±14, p ′ (p=0.011) using multivariate regression analysis. Conclusions: Patients with unoperated significant MR have high mortality. Elevated PASP and mitral E/E′ were the most significant predictors of 5-year survival in patients with unoperated significant MR. Current American College of Cardiology (ACC)/American Heart Association (AHA) guidelines provide a limited incorporation of echo-Doppler parameters in the preoperative risk stratification of patients with severe MR.
- 27 October 2015
- Published by Wiley in Echocardiography
- Vol. 32 (11) , 1607
Continuing Medical Education Activity inEchocardiography
- 27 October 2015
- Published by Wiley in Echocardiography
- Vol. 32 (11) , 1607
Continuing Medical Education Activity inEchocardiography
- Open Access
- 17 March 2015
- Published by Wolters Kluwer Health in Circulation
- Vol. 131 (11) , 1031-1034
Echo-Doppler Hemodynamics
- 17 March 2015
- Published by Wolters Kluwer Health in Circulation
- Vol. 131 (11) , 1031-1034
Open AccessEcho-Doppler Hemodynamics
- 1 January 2015
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 23 (1) , 52-53
Q Fever Endocarditis in a Patient With Bioprosthetic Heart Valves
Q fever endocarditis, caused by Coxiella burnetii, is an uncommon disease that can be difficult to diagnose and often lead to significant morbidity and mortality. We describe a case of a 73-year-old woman with bioprosthetic aortic and mitral valves, who presented with nonspecific symptoms, negative blood cultures, and an unremarkable transthoracic echocardiogram. She was subsequently diagnosed with vasculitis. However, after several months with no improvement with steroid therapy, she was reevaluated and diagnosed with Q fever endocarditis by a positive serology for C. burnetii, along with transesophageal echocardiography, which demonstrated vegetations. In conclusion, this case highlights that Q fever is usually a form of culture-negative endocarditis that should be suspected on the differential diagnosis for patients, especially those with a history of exposure to farm animals and presence of prosthetic valves.
- 1 January 2015
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 23 (1) , 52-53
Q Fever Endocarditis in a Patient With Bioprosthetic Heart Valves
Q fever endocarditis, caused by Coxiella burnetii, is an uncommon disease that can be difficult to diagnose and often lead to significant morbidity and mortality. We describe a case of a 73-year-old woman with bioprosthetic aortic and mitral valves, who presented with nonspecific symptoms, negative blood cultures, and an unremarkable transthoracic echocardiogram. She was subsequently diagnosed with vasculitis. However, after several months with no improvement with steroid therapy, she was reevaluated and diagnosed with Q fever endocarditis by a positive serology for C. burnetii, along with transesophageal echocardiography, which demonstrated vegetations. In conclusion, this case highlights that Q fever is usually a form of culture-negative endocarditis that should be suspected on the differential diagnosis for patients, especially those with a history of exposure to farm animals and presence of prosthetic valves.
- 1 January 2014
- Published by Elsevier in The American Journal of Cardiology
- Vol. 113 (1) , 183-186
Comparison of the Effect on Right Atrial Pressure of Abdominal Compression Versus the Valsalva Maneuver
- 1 January 2014
- Published by Elsevier in The American Journal of Cardiology
- Vol. 113 (1) , 183-186
Comparison of the Effect on Right Atrial Pressure of Abdominal Compression Versus the Valsalva Maneuver
- 1 November 2013
- Vol. 22 (6) , 843-5
Competent mitral valve after annulus ring removal for infective endocarditis.
The mitral annulus plays an essential role in mitral valve (MV) competency. When surgical intervention is needed, the placement of an annular ring is considered a major component of MV repair. However, the use of a foreign material increases the risk of infectious and thromboembolic complications and is problematic in children as it does not allow for annular growth. Herein is reported a case of infective endocarditis affecting a mitral ring that was implanted to treat severe mitral valve regurgitation (MR) some 10 years earlier. Surgery was performed to remove the MV vegetation, and subsequent echocardiography revealed only trace MR. The concept that the ring may be needed for a limited period of time to induce valve remodeling is consistent with new data on biodegradable rings. These rings degrade over months, inducing dense fibrous tissue that replaces the ring and maintains valve competency. The present case is one of the first human examples to support the potential efficacy of a biodegradable ring.
- 1 November 2013
- Vol. 22 (6) , 843-5
Competent mitral valve after annulus ring removal for infective endocarditis.
The mitral annulus plays an essential role in mitral valve (MV) competency. When surgical intervention is needed, the placement of an annular ring is considered a major component of MV repair. However, the use of a foreign material increases the risk of infectious and thromboembolic complications and is problematic in children as it does not allow for annular growth. Herein is reported a case of infective endocarditis affecting a mitral ring that was implanted to treat severe mitral valve regurgitation (MR) some 10 years earlier. Surgery was performed to remove the MV vegetation, and subsequent echocardiography revealed only trace MR. The concept that the ring may be needed for a limited period of time to induce valve remodeling is consistent with new data on biodegradable rings. These rings degrade over months, inducing dense fibrous tissue that replaces the ring and maintains valve competency. The present case is one of the first human examples to support the potential efficacy of a biodegradable ring.